Literature DB >> 16810739

IL-4 induces expression of TARC/CCL17 via two STAT6 binding sites.

Gerald Wirnsberger1, Daniel Hebenstreit, Gernot Posselt, Jutta Horejs-Hoeck, Albert Duschl.   

Abstract

A cardinal feature of allergic disorders and immune responses is enhanced leukocyte trafficking. This is largely orchestrated by chemokines. The CC chemokine thymus- and activation-regulated chemokine (TARC/CCL17) selectively attracts Th2 cells via the G protein-coupled chemokine receptor CCR4. We show here that TARC/CCL17 is expressed by human T cells upon stimulation with IL-4. Mapping of the transcriptional start site revealed the presence of two putative STAT6 binding motifs in proximity to the start position. EMSA and chromatin immunoprecipitation experiments demonstrated that STAT6 was able to bind to both motifs. A fragment of the TARC/CCL17 promoter containing both sites was tested in reporter gene assays for IL-4 inducibility. The promoter was inducible in a STAT6-deficient cell line only after introduction of functional STAT6. When mutations were inserted into one of the STAT6 motifs, IL-4-induced promoter activation was reduced. With both sites mutated, inducibility was completely abrogated. These data demonstrate collectively that T cells serve as a source of TARC/CCL17 when stimulated with IL-4 and that STAT6 is essential for this.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16810739      PMCID: PMC2988193          DOI: 10.1002/eji.200635972

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  51 in total

1.  STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts.

Authors:  J Hoeck; M Woisetschläger
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

2.  The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells.

Authors:  J J Campbell; G Haraldsen; J Pan; J Rottman; S Qin; P Ponath; D P Andrew; R Warnke; N Ruffing; N Kassam; L Wu; E C Butcher
Journal:  Nature       Date:  1999-08-19       Impact factor: 49.962

3.  Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells.

Authors:  D D'Ambrosio; A Iellem; R Bonecchi; D Mazzeo; S Sozzani; A Mantovani; F Sinigaglia
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

4.  Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector.

Authors:  T Imai; T Yoshida; M Baba; M Nishimura; M Kakizaki; O Yoshie
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

5.  The Role of TARC in the Pathogenesis of Allergic Asthma.

Authors:  M. Cecilia Berin
Journal:  Drug News Perspect       Date:  2002-01

6.  Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6.

Authors:  J Hoeck; M Woisetschläger
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

7.  Assignment of the human CC chemokine gene TARC (SCYA17) to chromosome 16q13.

Authors:  H Nomiyama; T Imai; J Kusuda; R Miura; D F Callen; O Yoshie
Journal:  Genomics       Date:  1997-02-15       Impact factor: 5.736

8.  The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule alpha gene expression by a STAT6 and CCAAT/enhancer-binding protein-dependent mechanism.

Authors:  Adrian M Stütz; Louise A Pickart; Alexandre Trifilieff; Thomas Baumruker; Eva Prieschl-Strassmayr; Maximilian Woisetschläger
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

9.  Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis.

Authors:  Hirotoshi Furukawa; Koichiro Nakamura; Xuyei Zheng; Michiko Tojo; Noritaka Oyama; Hitoshi Akiba; Akiko Nishibu; Fumio Kaneko; Yuichiro Tsunemi; Hidehisa Saeki; Kunihiko Tamaki
Journal:  J Dermatol Sci       Date:  2004-06       Impact factor: 4.563

10.  Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.

Authors:  R Bonecchi; G Bianchi; P P Bordignon; D D'Ambrosio; R Lang; A Borsatti; S Sozzani; P Allavena; P A Gray; A Mantovani; F Sinigaglia
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

View more
  39 in total

Review 1.  An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii.

Authors:  Eric Y Denkers; David J Bzik; Barbara A Fox; Barbara A Butcher
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

2.  Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation.

Authors:  Lai Wei; Golnaz Vahedi; Hong-Wei Sun; Wendy T Watford; Hiroaki Takatori; Haydee L Ramos; Hayato Takahashi; Jonathan Liang; Gustavo Gutierrez-Cruz; Chongzhi Zang; Weiqun Peng; John J O'Shea; Yuka Kanno
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

Review 3.  Targeting key proximal drivers of type 2 inflammation in disease.

Authors:  Namita A Gandhi; Brandy L Bennett; Neil M H Graham; Gianluca Pirozzi; Neil Stahl; George D Yancopoulos
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

4.  IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytes.

Authors:  Francesco Borriello; Michele Longo; Rosa Spinelli; Antonio Pecoraro; Francescopaolo Granata; Rosaria Ilaria Staiano; Stefania Loffredo; Giuseppe Spadaro; Francesco Beguinot; John Schroeder; Gianni Marone
Journal:  Eur J Immunol       Date:  2015-04-28       Impact factor: 5.532

5.  Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome.

Authors:  Florence Roufosse; Aurore de Lavareille; Liliane Schandené; Elie Cogan; Ann Georgelas; Lori Wagner; Liqiang Xi; Mark Raffeld; Michel Goldman; Gerald J Gleich; Amy Klion
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

6.  Inhibition of suppressive T cell factor 1 (TCF-1) isoforms in naive CD4+ T cells is mediated by IL-4/STAT6 signaling.

Authors:  Elisabeth Maier; Daniel Hebenstreit; Gernot Posselt; Peter Hammerl; Albert Duschl; Jutta Horejs-Hoeck
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

7.  Distinct signal codes generate dendritic cell functional plasticity.

Authors:  Kazuhiko Arima; Norihiko Watanabe; Shino Hanabuchi; Mikyoung Chang; Shao-Cong Sun; Yong-Jun Liu
Journal:  Sci Signal       Date:  2010-01-19       Impact factor: 8.192

8.  SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients.

Authors:  George P Christophi; Chad A Hudson; Ross C Gruber; Christoforos P Christophi; Cornelia Mihai; Luis J Mejico; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2008-01-21       Impact factor: 5.662

9.  LEF-1 negatively controls interleukin-4 expression through a proximal promoter regulatory element.

Authors:  Daniel Hebenstreit; Marco Giaisi; Monika K Treiber; Xiao-Bin Zhang; Huai-Feng Mi; Jutta Horejs-Hoeck; Kristian G Andersen; Peter H Krammer; Albert Duschl; Min Li-Weber
Journal:  J Biol Chem       Date:  2008-06-25       Impact factor: 5.157

10.  Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.

Authors:  George P Christophi; Michael Panos; Chad A Hudson; Rebecca L Christophi; Ross C Gruber; Akos T Mersich; Scott D Blystone; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.